GH研究制药 GHRS
$18.61 +$0.17 (+0.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.61 0.00%
开盘$18.56
昨收$18.44
当日区间$18.13 – $18.78
成交量453.6K
市值$1.28B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例71.5%-3.78 个百分点，较上季度
持仓机构数75+3 ，较上季度
内部人近期交易4次买入 / 0次卖出净买入
空头持仓比例2.93% 占流通股回补天数 7.0 · 截至 15 Oct 2026
卖空成交量占比20.7%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$312.3K（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有70.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从3.69%降至2.93%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Y-Intercept (Hong Kong) Limited | Mutual Fund | 2026/Q3 | +170,315 | 0.2% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +3,333,334 | 4.9% |
| Lynx1 Capital Management LP | Mutual Fund | 2026/Q3 | +2,500,000 | 19.3% |
| FMR | Mutual Fund | 2026/Q3 | +841,000 | 8.7% |
| Foresite Capital Management, LLC | VC/PE Fund | 2026/Q3 | +625,001 | 1.4% |
| Braidwell LP | Hedge Fund | 2026/Q3 | +207,240 | 0.3% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +169,951 | 0.2% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +103,878 | 0.2% |
| Trexquant Investment LP | Hedge Fund | 2026/Q3 | +83,959 | 0.2% |
| Hudson River Trading LLC | Private Company | 2026/Q3 | +65,375 | 0.1% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +64,992 | 0.7% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +50,882 | 0.1% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +43,948 | 0.1% |
| Axxion S.A | Mutual Fund | 2026/Q3 | +36,170 | 0.1% |
| XTX Markets Limited | Private Company | 2026/Q3 | +34,896 | 0.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 7 Sep 2026 | Florian Schonharting | Co-Founder & Non-Executive Chairman of the Board | Other Derivative Acquisition | +2,303 | $0.03 | 2,303 |
| 10 Aug 2026 | Michael Forer | Independent Vice Chairperson | Other Derivative Acquisition | +102,202 | $0.03 | 100,000 |
| 10 Aug 2026 | Dermot Hanley | Independent Non-Executive Director | Other Derivative Acquisition | +2,202 | $0.03 | 2,202 |
| 10 Aug 2026 | Duncan Moore | Independent Non-Executive Director | Other Derivative Acquisition | +2,202 | $0.03 | 2,202 |
| 31 Mar 2026 | Florian Schonharting | Co-Founder & Non-Executive Chairman of the Board | Initial Statement of Beneficial | +0 | – | 14,824,419 |
| 17 Mar 2026 | Michael Forer | Independent Vice Chairperson | Initial Statement of Beneficial | +0 | – | 72,340 |
| 17 Mar 2026 | Dermot Hanley | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 72,340 |
| 17 Mar 2026 | Duncan Moore | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 72,340 |
| 17 Mar 2026 | Magnus Halle | Co-Founder & MD of Ireland | Initial Statement of Beneficial | +0 | – | 217,500 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 2,010,434 | 2.9% | 7.0 |
| 30 Sep 2026 | 1,763,436 | 2.6% | 5.0 |
| 15 Sep 2026 | 2,702,630 | 3.9% | 14.3 |
| 31 Aug 2026 | 3,081,748 | 4.5% | 18.5 |
| 14 Aug 2026 | 3,144,599 | 4.6% | 7.0 |
| 31 Jul 2026 | 2,529,977 | 3.7% | 7.3 |
暂无评论——快来第一个聊聊 GHRS。
登录后参与讨论。